Life Science

HDAC inhibitor used to treat T cell lymphoma. It also induces apoptosis in pancreatic cancer cells and decreases HIV release from macrophages.

HDAC inhibitor used to treat T cell lymphoma. It also induces apoptosis in pancreatic cancer cells and decreases HIV release from macrophages.

Thiamine/vitamin B derivative and antioxidant. It displays several biological activities, including inhibiting pain neurotransmission, decreasing production of production of amyloid-&beta, and inhibiting LPS-induced release of leukotrienes,

Thiamine/vitamin B derivative and antioxidant. It displays several biological activities, including inhibiting pain neurotransmission, decreasing production of production of amyloid-&beta, and inhibiting LPS-induced release of leukotrienes,

Thiamine/vitamin B derivative and antioxidant. It displays several biological activities, including inhibiting pain neurotransmission, decreasing production of production of amyloid-&beta, and inhibiting LPS-induced release of leukotrienes,

An inhibitor of AADC, an enzyme that has dopamine decarboxylase activity, to block the conversion of L-DOPA to dopamine by AADC in the peripheral circulatory system.

An inhibitor of AADC, an enzyme that has dopamine decarboxylase activity, to block the conversion of L-DOPA to dopamine by AADC in the peripheral circulatory system.

An inhibitor of AADC, an enzyme that has dopamine decarboxylase activity, to block the conversion of L-DOPA to dopamine by AADC in the peripheral circulatory system.

An inhibitor of AADC, an enzyme that has dopamine decarboxylase activity, to block the conversion of L-DOPA to dopamine by AADC in the peripheral circulatory system.

The Benz-Neburase is a genetically engineered endonuclease from Serratia marcescens used as a DNA eraser in the purification processes of biological molecules. The enzyme cleaves all forms of DNA and RNA into smaller nucleotides of around 5-8 base

An inhibitor of URAT1 (IC₅₀ = 0.3 &microM for hURAT1) that prevents renal urate resorption also potently inhibits CYP2C9 (Ki = 20 nM) and has been used to study adverse drug-drug interactions.

An inhibitor of URAT1 (IC₅₀ = 0.3 &microM for hURAT1) that prevents renal urate resorption also potently inhibits CYP2C9 (Ki = 20 nM) and has been used to study adverse drug-drug interactions.